Clinical Trials Directory

Trials / Unknown

UnknownNCT03525522

Nd:Yttrium Aluminum Garnet Laser Treatment for Lichen Sclerosus

Efficacy of Nd:Yttrium Aluminum Garnet Laser Treatment of Lichen Sclerosus

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Dr Adolf Lukanovič · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the efficacy of Nd:Yttrium Aluminum Garnet Laser (Nd:YAG) Treatment of Lichen sclerosus in comparison with topical corticosteroid treatment. Half of participants will receive laser treatment and the other half corticosteroid treatment and the results will be followed for 6 months.

Detailed description

Lichen sclerosus (LS) is a chronic skin disease of unknown cause and very unpleasant symptoms which significantly influences the quality of life of the affected patients. Large majority of LS lesions is located in anogenital region where initial white flat papules usually develop into large, white patches of thin, itchy skin causing fusion of labia minora, narrowing of the introitus and burying of the clitoris. Most common symptoms are itching, pain, soreness, burning, dyspareunia and dysuria all strongly interfering with sexual function and patient's self image. Existing treatment options with systemic and topical medications (oral retinoids, topical steroids) have some drawbacks and recently the use of laser was proposed for treatment of LS. This study evaluates the safety and efficacy of Nd:Yttrium Aluminum Garnet Laser (Nd:YAG) Treatment of Lichen sclerosus in comparison with topical corticosteroid treatment. Half of participants will receive laser treatment and the other half corticosteroid treatment and the results will be followed for 6 months.

Conditions

Interventions

TypeNameDescription
DEVICENd:YAG LaserThree sessions of Nd:YAG treatment every two weeks.
DRUGTopical corticosteroid Diprosone3 months of topical corticosteroids Diprosone

Timeline

Start date
2016-01-28
Primary completion
2018-05-30
Completion
2018-05-30
First posted
2018-05-15
Last updated
2018-05-15

Source: ClinicalTrials.gov record NCT03525522. Inclusion in this directory is not an endorsement.